Yesterday, the Green Ribbon Panel issued a statement emphasizing the importance of Canada-US economic cooperation to secure a sustainable energy future and strengthen ...

Avec Les Echos suivez en temps réel toute l'actualité financière puisée aux meilleures sources des sociétés cotées.

Mumbai: Cipla, an Indian multinational pharmaceutical company, has announced that the United States Food and Drugs ...

In the medical device industry, FDA inspections are not a regulatory hurdle — they are a powerful tool for improving product ...

As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, ...

From turning away inspectors to falsifying data and leaving "bare footprints" in production containers, two of the latest ...

Mumbai: Piramal Pharma has announced that the Company has received six observations from US Food and Drug Administration ...

IST, the barometer index, the S&P BSE Sensex, advanced 105.44 points or 0.14% to 76,073.40. The Nifty 50 index rose 8.25 points or 0.04% to 22,953.55.

Piramal Pharma slipped 1.14% to Rs 195.40 after the US FDA issued a Form-483 with 6 observations to the company's Turbhe facility post a GMP inspection.

Piramal Pharma shares will be in focus after the US FDA's GMP inspection at its Turbhe facility from February 11-17, 2025, ...

Here’s a quick look at stocks likely to be in focus in today's trade. Tata Steel: Tata Steel Ltd announced that the Neath ...